NICE recommends andexanet alfa (ONDEXXYA®▼) for uncontrolled bleeds in the gastrointestinal tractApril 6, 2021
GSK presents positive efficacy data of dostarlimab in mismatch repair-deficient (dMMR) solid cancersJanuary 18, 2021
New data show positive association between Remsima® SC pre-dose level with efficacy outcomesOctober 14, 2020